Vazey Elena M, Chen Kevin, Hughes Stephanie M, Connor Bronwen
Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
Exp Neurol. 2006 Jun;199(2):384-96. doi: 10.1016/j.expneurol.2006.01.034. Epub 2006 Apr 19.
The present study investigated the ability for adult rat neural progenitor cells to survive transplantation, structurally repopulate the striatum and improve motor function in the quinolinic acid (QA) lesion rat model of Huntington's disease. Neural progenitor cells were isolated from the subventricular zone of adult Wistar rats, propagated in culture and labeled with BrdU (50 microM). Fourteen days following QA lesioning, one group of rats (n = 12) received a unilateral injection of adult neural progenitor cells ( approximately 180,000 cells total) in the lesioned striatum, while a second group of rats (n = 10) received a unilateral injection of vehicle only (sham transplant). At the time of transplantation adult neural progenitor cells were phenotypically immature, as demonstrated by SOX2 immunocytochemistry. Eight weeks following transplantation, approximately 12% of BrdU-labeled cells had survived and migrated extensively throughout the lesioned striatum. Double-label immunocytochemical analysis demonstrated that transplanted BrdU-labeled progenitor cells differentiated into either astrocytes, as visualized by GFAP immunocytochemistry, or mature neurons, demonstrated with NeuN. A proportion of BrdU-labeled cells also expressed DARPP-32 and GAD67, specific markers for striatal medium spiny projection neurons and interneurons. Rats transplanted with adult neural progenitor cells also demonstrated a significant reduction in motor function impairment as determined by apomorphine-induced rotational asymmetry and spontaneous exploratory forelimb use when compared to sham transplanted animals. These results demonstrate that adult neural progenitor cells survive transplantation, undergo neuronal differentiation with a proportion of newly generated cells expressing markers characteristic of striatal neurons and reduce functional impairment in the QA lesion model of Huntington's disease.
本研究调查了成年大鼠神经祖细胞在喹啉酸(QA)损伤的亨廷顿病大鼠模型中存活移植、在纹状体中进行结构重建并改善运动功能的能力。从成年Wistar大鼠的脑室下区分离神经祖细胞,在培养中进行增殖并用BrdU(50微摩尔)标记。QA损伤14天后,一组大鼠(n = 12)在损伤的纹状体中接受单侧注射成年神经祖细胞(总共约180,000个细胞),而另一组大鼠(n = 10)仅接受单侧注射赋形剂(假移植)。移植时,成年神经祖细胞在表型上不成熟,这通过SOX2免疫细胞化学得以证明。移植8周后,约12%的BrdU标记细胞存活并广泛迁移至损伤的纹状体中。双重标记免疫细胞化学分析表明,移植的BrdU标记祖细胞分化为星形胶质细胞(通过GFAP免疫细胞化学可视化)或成熟神经元(通过NeuN证明)。一部分BrdU标记细胞还表达DARPP - 32和GAD67,这是纹状体中等棘状投射神经元和中间神经元的特异性标记物。与假移植动物相比,移植成年神经祖细胞的大鼠在阿扑吗啡诱导的旋转不对称和自发探索性前肢使用方面所确定的运动功能损伤也显著降低。这些结果表明,成年神经祖细胞在移植后存活,经历神经元分化,一部分新生成的细胞表达纹状体神经元的特征性标记物,并减少了亨廷顿病QA损伤模型中的功能损伤。